Income Statement
HUMACYTE, INC.
HUMA
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY |
|---|---|---|---|---|---|---|
|
Revenue
|
2.04 | - | - | - | - | - |
|
Cost of Revenue
|
9.70 | - | - | - | - | - |
|
Gross Profit
|
-7.66 | - | - | - | - | - |
|
Operating Expenses
|
100.47 | 114.40 | 100.05 | 86.14 | 82.47 | 0.00 |
|
Research & Development
|
69.30 | 88.60 | 76.55 | 63.26 | 61.34 | - |
|
Selling, General & Administrative
|
31.17 | 25.80 | 23.50 | 22.88 | 21.13 | - |
|
Other Operating Expenses
|
- | - | - | - | - | - |
|
Operating Income
|
-108.14 | -114.40 | -100.05 | -86.14 | -82.47 | - |
|
Non-Operating Income
|
67.30 | -34.30 | -10.73 | 72.61 | 54.73 | - |
|
Interest Income
|
2.59 | 4.10 | 5.47 | 2.63 | 0.02 | - |
|
Interest Expense
|
8.74 | 7.70 | 6.60 | 6.20 | 4.35 | - |
|
Other Non-Op Income / Expense
|
- | - | - | - | - | - |
|
Income Before Tax
|
-40.83 | - | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - |
|
Net Income
|
-40.83 | -148.70 | -110.78 | -11.97 | -26.48 | - |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY |
|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - |
|
EBITDA
|
-108.14 | -114.40 | -100.05 | -86.14 | -82.47 | 0.00 |
|
Earnings Per Share (Basic)
|
-0.26 | -1.26 | -1.07 | -0.12 | -0.66 | - |
|
Diluted EPS
|
-0.26 | -1.26 | -1.07 | -0.12 | -0.66 | - |
|
Weighted Average Shares
|
158.16 | 118.48 | 103.42 | 103.05 | 39.97 | - |
|
Diluted Weighted Avg Shares
|
158.16 | 118.48 | 103.42 | 103.05 | 39.97 | - |
|
Comprehensive Income
|
- | -148.70 | -110.78 | -11.97 | -26.48 | - |